(Q35060364)

6 August 2017

title

Intravitreal injection of methotrexate in an experimental rabbit model: determination of pharmacokinetics (English)

1 reference

6 August 2017

1 reference

1 reference

Ebru Bener Ozkan

1

1 reference

6 August 2017

Altan A Ozcan

series ordinal

2

1 reference

6 August 2017

Nazan Alparslan

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

Indian Journal of Ophthalmology

6 August 2017

published in

1 reference

6 August 2017

volume

59

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

197-200

1 reference

Primary central nervous system lymphoma presenting as bilateral uveitis in an immunocompetent hepatitis C virus(+) patient: a case report

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120238

Clinical review: treatment of vitreoretinal lymphoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120238

Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120238

Chemotherapeutic dose intensification for treatment of malignant brain tumors: recent developments and future directions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120238

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120238

Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120238

Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120238

Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120238

Intraocular methotrexate level after high-dose intravenous infusion

25 October 2018

1 reference

12 December 2020

Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement

1 reference

12 December 2020

Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy

1 reference

12 December 2020

Intraocular levels of methotrexate after intravenous administration

1 reference

12 December 2020

Natural killer/T-cell lymphoma of nasal type with intraocular involvement: case report

1 reference

12 December 2020

[Intravitreal chemotherapy for intraocular lymphoma]

1 reference

12 December 2020

Identifiers

DOI

10.4103/0301-4738.81026

1 reference

6 August 2017

1 reference

6 August 2017

1 reference